newsfilter
← Latest News
Business Wire·

Five Prime Therapeutics to Announce Third Quarter 2019 Financial Results and Host Conference Call

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, will report its third quarter 2019 financial results on Wednesday, November 6, 2019 after the U.S. financial markets close. Five Prime will also host a conference call and live audio webcast on Wednesday, November 6, 2019 at 4:30 p.m. (ET) / 1:30 p.m. (PT) to discuss the company’s financial results and provide a general business update.